drugset / Trial / NCT00006153
Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
Phase 1
Terminated
45 enrolled
National Institute of Allergy and Infectious Diseases (NIAID)
The Immune Response Corporation · collab
Double-blindTreatment
Summary
The purpose of this study is to see if giving a vaccine (Remune) is effective in HIV-positive patients who are also taking anti-HIV therapy. Regular treatment of HIV-positive patients with anti-HIV drugs slows the multiplication of the HIV virus in the body. A vaccine called Remune works to stop the virus infection by "boosting" the body's immune cell defense against the HIV virus before the virus enters cells. It also blocks the virus from entering the cells. This study will see whether Remune will improve the immune cell natural defense in patients who are also taking anti-HIV drugs.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HIV-1 Immunogen | Vaccine | — | — |